scispace - formally typeset
A

Augustin Scalbert

Researcher at International Agency for Research on Cancer

Publications -  282
Citations -  51745

Augustin Scalbert is an academic researcher from International Agency for Research on Cancer. The author has contributed to research in topics: European Prospective Investigation into Cancer and Nutrition & Medicine. The author has an hindex of 86, co-authored 253 publications receiving 45489 citations. Previous affiliations of Augustin Scalbert include Université Paris-Saclay & University of Auvergne.

Papers
More filters
Journal ArticleDOI

Polyphenols: food sources and bioavailability

TL;DR: The nature and contents of the various polyphenols present in food sources and the influence of agricultural practices and industrial processes are reviewed, and bioavailability appears to differ greatly between the variousPolyphenols, and the most abundantpolyphenols in the authors' diet are not necessarily those that have the best bioavailability profile.
Journal ArticleDOI

Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies

TL;DR: Gallic acid and isoflavones are the most well-absorbed polyphenols, followed by catechins, flavanones, and quercetin glucosides, but with different kinetics, and the least well- absorption polyphenol are the proanthocyanidins, the galloylated tea catech ins, andThe anthocyanins.
Journal ArticleDOI

Dietary Intake and Bioavailability of Polyphenols

TL;DR: Both chemical and biochemical factors that affect the absorption and metabolism of polyphenols are reviewed, with particular emphasis on flavonoid glycosides.
Journal ArticleDOI

Dietary polyphenols and the prevention of diseases

TL;DR: Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases, cancers, neurodegenerative diseases, diabetes, or osteoporosis, but no clear associations have been found between cancer risk and polyphenol consumption.
Journal ArticleDOI

HMDB 3.0—The Human Metabolome Database in 2013

TL;DR: New database visualization tools and new data content have been added or enhanced to the HMDB, which includes better spectral viewing tools, more powerful chemical substructure searches, an improved chemical taxonomy and better, more interactive pathway maps.